These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7744980)

  • 1. The changing management of diabetic nephropathy.
    Dunfee TP
    Hosp Pract (1995); 1995 May; 30(5):45-9, 53-5. PubMed ID: 7744980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term glycemic control, low protein diet and administration of enalapril on renal hemodynamics and protein permselectivity in type 2 diabetic patients with microalbuminuria.
    Narita T; Koshimura J; Suzuki K; Murata M; Meguro H; Fujita H; Kitazato H; Ito S
    Tohoku J Exp Med; 1999 Oct; 189(2):117-33. PubMed ID: 10775055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic interventions for nephropathy in type I diabetes mellitus.
    Breyer JA
    Semin Nephrol; 1997 Mar; 17(2):114-23. PubMed ID: 9148377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy.
    Castellino P; Tuttle KR; DeFronzo RA
    Curr Ther Endocrinol Metab; 1994; 5():426-36. PubMed ID: 7704768
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M; Larger E
    Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Considerations on the treatment of incipient diabetic nephropathy (lst of 2 parts)].
    Pérez Blanco FJ; Manzanares L; Moreno G; Cabello MJ
    An Med Interna; 1996 Apr; 13(4):193-7. PubMed ID: 8688481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic nephropathy].
    Haneda M
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():260-9. PubMed ID: 12430239
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.
    Baba T; Neugebauer S; Watanabe T
    Drugs; 1997 Aug; 54(2):197-234. PubMed ID: 9257079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and therapeutic aspects of diabetic nephropathy.
    Strippoli GF; Di Paolo S; Cincione R; Di Palma AM; Teutonico A; Grandaliano G; Schena FP; Gesualdo L
    J Nephrol; 2003; 16(4):487-99. PubMed ID: 14696750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and ACE inhibitors.
    Boulton AJ; Gokal R
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():63-6; discussion 66-7. PubMed ID: 2283656
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].
    Schwarz C; Oberbauer R
    Wien Klin Wochenschr; 2000 Nov; 112(21):907-11. PubMed ID: 11144004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy.
    Parving HH; Hovind P
    Curr Hypertens Rep; 2002 Oct; 4(5):387-93. PubMed ID: 12217258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R; Mogyorósi A; Ziyadeh FN
    Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition and diabetic nephropathy.
    Beaufils M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S33-8. PubMed ID: 1382163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment recommendations for various stages in diabetic nephropathy].
    Takane H; Suzuki H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():379-83. PubMed ID: 15999738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.